Imodium and Triatec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium (loperamide hydrochloride) and Triatec (ramipril). Common drug interactions include renal failure acute among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium and Triatec. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium?

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.

What is Triatec?

Triatec has active ingredients of ramipril. eHealthMe is studying from 4,133 Triatec users. Check the latest studies of Triatec.

On Aug, 06, 2026

22 people who take Imodium and Triatec together, and have interactions are studied.

What are the common drug interactions of Imodium and Triatec, by gender? *:

female:

Renal failure acute (rapid kidney dysfunction)
Acute generalised exanthematous pustulosis (acute febrile drug eruption)
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Activated partial thromboplastin time prolonged
Blood pressure decreased
Bone disorder
Dehydration (dryness resulting from the removal of water)
Glomerulonephropathy (any noninflammatory disease of the renal glomeruli)
International normalised ratio increased

male:

Decreased appetite
Weight decreased
Thrombosis (formation of a blood clot inside a blood vessel)
Weight increased
Depressed mood
Dyspnoea exertional (breathlessness or shortness of breath)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dehydration (dryness resulting from the removal of water)
Generalised oedema (swelling all over the body)
Kidney fibrosis (excess fibrous connective tissue in kidney)

What are the common drug interactions of Imodium and Triatec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
Retinal vein occlusion (a blockage of the small veins that carry blood away from the retina)
Uveitis (inflammation of the uvea)

50-59:

Cerebral infarction (less blood supply to brain resulting tissue damage)
Acute generalised exanthematous pustulosis (acute febrile drug eruption)
Renal failure acute (rapid kidney dysfunction)
Glomerulonephropathy (any noninflammatory disease of the renal glomeruli)
Renal failure (kidney dysfunction)

60+:

Decreased appetite
Weight decreased
Weight increased
Dehydration (dryness resulting from the removal of water)
Depressed mood
Dyspnoea exertional (breathlessness or shortness of breath)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Activated partial thromboplastin time prolonged
Blood pressure decreased
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 31.82%
Pulmonary Embolism (blockage of the main artery of the lung): 5 people, 22.73%
Lung Neoplasm Malignant (cancer tumour of lung): 5 people, 22.73%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 4 people, 18.18%
Gastroenteritis (inflammation of stomach and intestine): 2 people, 9.09%
Essential Thrombocythaemia (chronic blood cancer): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium and Triatec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously